Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent
Main Authors: | , , , , , |
---|---|
格式: | 文件 |
语言: | English |
出版: |
BMC
2023-05-01
|
丛编: | Journal of Translational Medicine |
在线阅读: | https://doi.org/10.1186/s12967-023-04186-4 |